Health insurance premiums are set to increase significantly in 2026 due to growing medical claims, costly new therapies, and reduced government support in the individual marketplace. Employer plans may also shift more costs to employees.
Maine faces proposed health insurance rate increases up to 32% in 2026 driven by rising drug costs, limited competition, Medicaid changes, and expiring premium tax credits.
Explore the latest developments in Medicare for 2025 including UnitedHealthcare's market exits, anticipated drug price increases, new rural hospital funding legislation, and changes to Medicare Savings Programs affecting coverage and costs.
Analysis shows a 25% increase in U.S. private insurer prescription drug denials from 2016-2023, driven by rising drug costs and claim automation. Insights into industry impact and reform efforts.
Learn how to avoid lifetime Medicare Part D penalties by timely enrollment, understanding creditable coverage, and utilizing Extra Help financial assistance programs.
Vermont passes laws capping hospital outpatient drug prices and implementing reference-based pricing to reduce health care costs and insurance premiums.
President Trump's latest executive order modifies the Medicare Drug Price Negotiation Program, aligning the treatment of small molecule drugs with biologics and aiming to reduce drug prices.
Explore the influence of the Inflation Reduction Act on Medicare's prescription cost caps, reducing financial toxicity for patients.
AARP's new report reveals that the prices of top Medicare prescription drugs have nearly doubled over the past decade, raising concerns about affordability for seniors. Discover the implications and legislative efforts to address this crisis.
